BioCardia, Inc.
BioCardia, Inc. (BCDA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCDA · as of Jun 8, 2026
Key Statistics
Explore BioCardia, Inc. Data
bcda stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
Competitors & Peers
bcda competitorsBCDA
ACXP
ADIL
ALZN
APRE
APVOStock Performance
Full HistoryAbout BioCardia, Inc.
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respir…
what is biocardia, inc. · bcda stock overview · biocardia, inc. company profile · who is biocardia, inc. ceo · bcda NASDAQ · biocardia, inc. headquarters · biocardia, inc. business segments
About Stock Overview & Key Data
BioCardia, Inc. (BCDA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 13, 1996. As of the latest trading session, BCDA stock price is $0.92, with a market capitalization of $5.3M. The stock has returned -58.93% over the past 12 months and -26.40% year-to-date.
According to 5 Wall Street analysts, the consensus rating for BioCardia, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, BioCardia, Inc. reported revenue of — and net income of -$8.2M. For detailed data — including BioCardia, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioCardia, Inc. (BCDA) stock price is $0.92. The stock is traded on NASDAQ under the ticker symbol BCDA. The 52-week range is $0.84 – $2.45.